Found 0 matching trials
COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU N/A This is a retrospective observational cohort study. About 1000 hospital cha...
Show More Location
City Clinical Hospital No. 52 of the Department of Health of the City of Moscow
Learn More & Join Trial
Treatment Strategy for Patients With RA-ILD PHASE4 This is a 52-week, multicenter, prospective, open-label, randomized control...
Show More Location
The First Affiliated Hospital of Henan University of Science and Technology
Learn More & Join Trial
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate PHASE3 The administration of Janus kinase (JAK) inhibitors as well as biological d...
Show More Location
Nagasaki University Hospital
Learn More & Join Trial
Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection PHASE3 The COVID-19 infection primarily manifests itself as a respiratory tract in...
Show More Location
Fundação São Francisco Xavier
Learn More & Join Trial
Tocilizumab Plus a Short Prednisone Taper for GCA PHASE4 This is an open-label pilot study of tocilizumab (TCZ) 162 mg weekly admini...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA PHASE2 AION is the main cause of blindness in patients with GCA. High dose steroid...
Show More Location
CHU de Caen - Hôpital de la Côte de Nacre
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma PHASE1 This is a first-in human, open-label, Phase 1 dose-escalation study in orde...
Show More Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma PHASE1 This study will evaluate the safety, tolerability, pharmacokinetics, pharma...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham School of Medicine
Learn More & Join Trial
Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis PHASE1 Primary Objective:
To describe the safety and tolerability, including labo...
Show More Location
Investigational Site Number 392001
Learn More & Join Trial
Treatment of COVID-19 Patients With Anti-interleukin Drugs PHASE3 The purpose of this study is to test the safety and effectiveness of indivi...
Show More Location
AZ Sint-Jan Brugge
Learn More & Join Trial